Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
index medicus (15) 15
breast cancer (14) 14
female (12) 12
estrogen receptor (10) 10
estrogen (9) 9
oncology (8) 8
tamoxifen (8) 8
fes pet (7) 7
pet (7) 7
positron-emission-tomography (7) 7
breast neoplasms - metabolism (6) 6
imaging (6) 6
middle aged (6) 6
positron-emission tomography (6) 6
treatment outcome (6) 6
adult (5) 5
aged (5) 5
cancer (5) 5
estradiol - analogs & derivatives (5) 5
heterogeneity (5) 5
history (5) 5
radiology, nuclear medicine & medical imaging (5) 5
receptors, estrogen - metabolism (5) 5
therapy (5) 5
androgen receptor (4) 4
animals (4) 4
antiquities (4) 4
breast neoplasms - diagnostic imaging (4) 4
breast neoplasms - drug therapy (4) 4
care and treatment (4) 4
expression (4) 4
fulvestrant (4) 4
letrozole (4) 4
metabolic flare (4) 4
metastasis (4) 4
ovarian cancer (4) 4
postmenopausal women (4) 4
biopsy (3) 3
breast (3) 3
breast neoplasms - diagnosis (3) 3
church history (3) 3
endothelial growth-factor (3) 3
estradiol - therapeutic use (3) 3
hematology, oncology and palliative medicine (3) 3
history and criticism (3) 3
immunohistochemistry (3) 3
in-vivo (3) 3
male (3) 3
oestrogen receptor (3) 3
pet imaging (3) 3
phase-ii (3) 3
phase-ii trial (3) 3
progesterone (3) 3
tumor microenvironment (3) 3
tumors (3) 3
abiraterone acetate (2) 2
adrenal androgens (2) 2
advanced breast-cancer (2) 2
aged, 80 and over (2) 2
alpha (2) 2
androgen receptor expression (2) 2
androgens (2) 2
antineoplastic agents - therapeutic use (2) 2
ar antagonist (2) 2
beta (2) 2
bible (2) 2
biological transport (2) 2
bone (2) 2
breast neoplasms - pathology (2) 2
breast-cancer (2) 2
carcinoma, ovarian epithelial (2) 2
cardiology (2) 2
cell-proliferation (2) 2
cells (2) 2
center experience (2) 2
christian literature, early (2) 2
civilization (2) 2
clinical value (2) 2
clinical-significance (2) 2
computer science (2) 2
confidence intervals (2) 2
diagnosis (2) 2
dna methylation (2) 2
endocrine therapy (2) 2
endometrial stromal sarcoma (2) 2
epidermal growth factor (2) 2
estradiol (2) 2
estradiol - metabolism (2) 2
estrogen receptors (2) 2
estrogen-receptors (2) 2
estrogens (2) 2
f-18-fes pet (2) 2
f-18-fluoroestradiol (2) 2
feasibility studies (2) 2
festschriften (2) 2
fluorine-18-labeled estrogens (2) 2
genes (2) 2
hdac inhibitors (2) 2
histoire (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma
by Oude Munnink, Thijs and van der Meer, Alex and de Haan, Jacco and Touw, Daan and van Kruchten, Michel
Therapeutic Drug Monitoring, ISSN 0163-4356, 12/2019, Volume 41, Issue 6, pp. 693 - 695
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16a-18F-fluoro-17b-estradiol PET/CT
by Van Kruchten, Michel and De Vries, Erik F.J and Arts, Henriette J.G and Jager, Neeltina M and Bongaerts, Alphons H.H and Glaudemans, Andor W.J.M and Hollema, Harry and De Vries, Elisabeth G.E and Hospers, Geke A.P and Reyners, Anna K.L
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 50 - 55
FES PET | Estrogen receptor | Imaging | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text FES PET/CT analysis to evaluate the impact of localization of breast cancer metastases on ER expression
by Nienhuis, Hilde H and van Kruchten, Michel and Glaudemans, Andor W. J. M and Bongaerts, Alfons H. H and de Vries, Erik and Schroder, Carolina Pia and de Vries, Elisabeth G. E and Hospers, Geke
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. 527 - 527
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text PET imaging of oestrogen receptors in patients with breast cancer
by van Kruchten, Michel, MD and de Vries, Elisabeth G E, Prof and Brown, Myles, Prof and de Vries, Erik F J, PhD and Glaudemans, Andor W J M, MD and Dierckx, Rudi A J O, Prof and Schröder, Carolien P, MD and Hospers, Geke A P, Prof
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. e465 - e475
Summary Oestrogen receptors are overexpressed in around 70% of all breast cancers, and are a target for endocrine therapy. These receptors can be visualised on... 
Hematology, Oncology and Palliative Medicine | FES PET | METABOLIC FLARE | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | FLUORINE-18-LABELED ESTROGENS | TAMOXIFEN | IN-VIVO | ALPHA | HORMONE-BINDING GLOBULIN | UTERINE-TUMORS | BETA | Receptors, Estrogen - metabolism | Animals | Humans | Female | Breast Neoplasms - diagnosis | Positron-Emission Tomography | Breast Neoplasms - metabolism | Pets | Care and treatment | PET imaging | Estrogen | Breast cancer | Metastasis | Tumor proteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Residual estrogen receptor availability during fulvestrant 500 mg therapy in patients with metastatic breast cancer
by van Kruchten, Michel and de Vries, Elisabeth G. E and Brown, Myles and Glaudemans, Andor W. J. M and van Lanschot, Meta C and Kema, Ido P and Van Faassen, Martijn and Schroder, Carolien P and De Vries, Erik F. J and Hospers, Geke
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 588 - 588
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16[Alpha]- sigma up 18 Theta -Fluoro-17[Beta]-Estradiol PET/CT
by van Kruchten, Michel and de Vries, Erik FJ and Arts, Henriette JG and Jager, Neeltina M and Bongaerts, Alphons HH and Glaudemans, Andor WJM and Hollema, Harry and de Vries, Elisabeth GE and Hospers, Geke AP and Reyners, Anna KL
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 50 - 50
The estrogen receptor (ER) is expressed in approximately 70% of ovarian cancer tumors. PET of tumor ER expression with the tracer 16-18F-fluoro-17-estradiol... 
Journal Article
Details down arrow
7. Full Text Abstract 4768: Frequency and prognostic value of hormone receptor expression in epithelial ovarian cancer
by van Kruchten, Michel and van der Marel, Pauline W and Arts, Henriëtte J.G and Hollema, Harry and de Munck, Linda and van der Sluis, Tineke and Timmer-Bosscha, Hetty and Hospers, Geke A.P and Reyners, An K.L
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 4768 - 4768
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Whole-body PET imaging of breast cancer characteristics to improve precision treatment
by Hospers, Geke A.P and van Kruchten, Michel and de Vries, Elisabeth G. E
ONCOLOGY (United States), ISSN 0890-9091, 05/2014, Volume 28, Issue 5, pp. 434 - 436
PROGESTERONE-RECEPTOR | ONCOLOGY | ESTROGEN-RECEPTOR | FACTOR RECEPTOR 2 | Female | Antineoplastic Agents - therapeutic use | Positron-Emission Tomography | Breast Neoplasms - diagnostic imaging | Breast Neoplasms - drug therapy | Humans
Journal Article
Details down arrow
9. Full Text PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
by van Kruchten, Michel and Glaudemans, Andor W. J. M and de Vries, Erik F. J and Beets-Tan, Regina G. H and Schroder, Carolien P and Dierckx, Rudi A and de Vries, Elisabeth G. E and Hospers, Geke A. P
Journal of Nuclear Medicine, ISSN 0161-5505, 02/2012, Volume 53, Issue 2, pp. 182 - 190
F-18-FES PET | estrogen receptor | breast cancer | clinical value | imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
by van Kruchten, Michel and Glaudemans, Andor WJM and de Vries, Erik FJ and Beets-Tan, Regina GH and Schroeder, Carolien P and Dierckx, Rudi A and de Vries, Elisabeth GE and Hospers, Geke AP
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2012, Volume 53, Issue 2, pp. 182 - 190
16 alpha -18F-fluoro-17 beta -estradiol (18F-FES) is an estrogen receptor (ER)-specific PET tracer with various potential interesting applications. The precise... 
Journal Article
Details down arrow
11. Full Text 18 F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
by Nienhuis, Hilde H and van Kruchten, Michel and Elias, Sjoerd G and Glaudemans, Andor W J M and de Vries, Erik F J and Bongaerts, Alfons H H and Schröder, Carolien P and de Vries, Elisabeth G E and Hospers, Geke A P
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 08/2018, Volume 59, Issue 8, p. 1212
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
by Falahi, Fahimeh and van Kruchten, Michel and Martinet, Nadine and Hospers, Geke AP and Rots, Marianne G
Breast Cancer Research, ISSN 1465-5411, 07/2014, Volume 16, Issue 4, p. 412
DNA methylation and histone modifications are important epigenetic modifications associated with gene (dys) regulation. The epigenetic modifications are... 
HDAC INHIBITORS | CELLS | HISTONE DEACETYLASE INHIBITOR | PHASE-II TRIAL | DNA METHYLATION | SOLID TUMORS | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | VALPROIC ACID | VORINOSTAT | MODULATION | Epigenomics | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Animals | Breast Neoplasms - genetics | Female | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Histones - metabolism | Drug Evaluation, Preclinical | DNA Methylation - drug effects | Antimitotic agents | Epigenetic inheritance | Care and treatment | Methyltransferases | Genes | Antineoplastic agents | Health aspects | Cancer | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer
by van Kruchten, Michel and de Vries, Elisabeth G and Glaudemans, Andor W and van Lanschot, Meta C and van Faassen, Martijn and Kema, Ido P and Brown, Myles and Schroder, Carolien P and de Vries, Erik F and Hospers, Geke A
Cancer discovery, ISSN 2159-8274, 01/2015, Volume 5, Issue 1, pp. 72 - 81
It is unknown whether the current dose of fulvestrant, an estrogen receptor (ER) antagonist, is sufficient for maximal ER downregulation in patients with... 
TRIAL | DIAGNOSIS | POSTMENOPAUSAL WOMEN | TAMOXIFEN | PET | TISSUE | ONCOLOGY | Estradiol - analogs & derivatives | Estradiol - therapeutic use | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Middle Aged | Estradiol - administration & dosage | Receptors, Estrogen - antagonists & inhibitors | Tomography, X-Ray Computed | Treatment Outcome | Positron-Emission Tomography | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Disease Progression | Antineoplastic Agents, Hormonal - pharmacokinetics | Estradiol - pharmacokinetics | Neoplasm Metastasis | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Female | Aged | Breast Neoplasms - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Positron emission tomography of tumour [F-18] fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
by van Kruchten, Michel and Glaudemans, Andor W. J. M and de Vries, Erik F. J and Schroder, Carolien P and de Vries, Elisabeth G. E and Hospers, Geke A. P
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2015, Volume 42, Issue 11, pp. 1674 - 1681
Purpose Whereas anti-oestrogen therapy is widely applied to treat oestrogen receptor (ER) positive breast cancer, paradoxically, oestrogens can also induce... 
CELLS | APOPTOTIC ACTION | TAMOXIFEN | ENDOCRINE-THERAPY | Breast cancer | Oestrogen receptor | TRIAL | Oestradiol therapy | RECOMMENDATIONS | Imaging | ESTROGEN-RECEPTOR-ALPHA | DIETHYLSTILBESTROL | F-18-FES-PET | BONE | POSTMENOPAUSAL WOMEN | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | 18 F-FES-PET | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Estradiol - metabolism | Predictive Value of Tests | Estradiol - analogs & derivatives | Estradiol - therapeutic use | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Treatment Outcome | Positron-Emission Tomography | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Biological Transport | Bone and Bones - metabolism | Biomarkers, Tumor - metabolism | Estradiol - adverse effects | Adult | Female | Aged | Breast Neoplasms - diagnostic imaging | Tomography | Metastasis | Positrons | Emissions | 18F-FES-PET | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text F-18-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
by Nienhuis, Hilde H and van Kruchten, Michel and Elias, Sjoerd G and Glaudemans, Andor W J M and de Vries, Erik F J and Bongaerts, Alfons H H and Schröder, Carolien P and de Vries, Elisabeth G E and Hospers, Geke A P
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, pp. 1212 - 1218
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
PROGESTERONE | estrogen receptor | breast cancer | FUTURE | ESTROGEN-RECEPTOR BINDING | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | EVOLUTION | IN-VIVO | RESISTANCE | ANDROGEN | tumor microenvironment | F-18-fluoroestradiol PET | PET | tumor heterogeneity | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
by van Kruchten, Michel and Glaudemans, Andor W. J. M and Beets-Tan, Regina G. H and Schroder, Carolien P and Dierckx, Rudi A and de Vries, Elisabeth G. E and Hospers, Geke A. P and de Vries, Erik
Journal of Nuclear Medicine, ISSN 0161-5505, 02/2012, Volume 53, Issue 2, pp. 182 - 190
16 alpha-F-18-fluoro-17 beta-estradiol (F-18-FES) is an estrogen receptor (ER)-specific PET tracer with various potential interesting applications. The precise... 
F-18-FES PET | METABOLIC FLARE | EFFICACY | estrogen receptor | breast cancer | imaging | UMCG Approved | HETEROGENEITY | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | ASSAYS | clinical value | EXPRESSION | Clinical value | Estrogen receptor | Breast cancer | F-FES PET | Imaging | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Estradiol - metabolism | Estradiol - analogs & derivatives | Receptors, Estrogen - metabolism | Humans | Middle Aged | Positron-Emission Tomography - methods | Breast Neoplasms - metabolism | Biological Transport | Adult | Female | Aged | Retrospective Studies | Breast Neoplasms - diagnostic imaging | Medicine | Studies | Confidence intervals | Decision making | Biopsy | Oncology | Family medical history | Abdomen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Hormone receptors as a marker of poor survival in epithelial ovarian cancer
by van Kruchten, Michel and van der Marel, Pauline and de Munck, Linda and Hollema, Harry and Arts, Henriette and Timmer-Bosscha, Hetty and de Vries, Elisabeth and Hospers, Geke and Reyners, Anna
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 138, Issue 3, pp. 634 - 639
Abstract Objective Androgen receptor (AR), estrogen receptor α and β (ERα, ERβ), and progesterone receptor (PR) are potential therapeutic targets in epithelial... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Estrogen receptor | Biomarker | Progesterone receptor | Androgen receptor | Ovarian cancer | TAMOXIFEN | PHASE-II | FLUTAMIDE | CHEMOTHERAPY | BREAST-CANCER | THERAPY | FULVESTRANT | EXPRESSION | CARCINOMA | OBSTETRICS & GYNECOLOGY | ONCOLOGY | LETROZOLE | INHIBITOR | Celecoxib - administration & dosage | Receptors, Estrogen - blood | Prognosis | Prospective Studies | Tissue Array Analysis | Humans | Middle Aged | Neoplasms, Glandular and Epithelial - blood | Receptors, Androgen - biosynthesis | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - drug therapy | Receptors, Androgen - blood | Docetaxel | Carboplatin - administration & dosage | Ovarian Neoplasms - blood | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Receptors, Estrogen - biosynthesis | Aged | Receptors, Progesterone - blood | Receptors, Progesterone - biosynthesis | Estrogen | Hormones
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16 alpha-F-18-Fluoro-17 beta-Estradiol PET/CT
by van Kruchten, Michel and de Vries, Erik F. J and Arts, Henriette J. G and Jager, Neeltina M and Bongaerts, Alphons H. H and Glaudemans, Andor W. J. M and Hollema, Harry and de Vries, Elisabeth G. E and Hospers, Geke A. P and Reyners, Anna K. L
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 50 - 55
The estrogen receptor a (ER alpha) is expressed in approximately 70% of ovarian cancer tumors. PET of tumor ER alpha expression with the tracer 16... 
FES PET | RESPONSIVENESS | estrogen receptor | ovarian cancer | TAMOXIFEN | imaging | BETA | BREAST-CANCER | PHASE-II TRIAL | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | LETROZOLE | F-18-FLUOROESTRADIOL | PROGESTERONE-RECEPTOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Consideration of breast cancer subtype in targeting the androgen receptor
by Venema, Clasina M and Bense, Rico D and Steenbruggen, Tessa G and Nienhuis, Hilde H and Qiu, Si-Qi and van Kruchten, Michel and Brown, Myles and Tamimi, Rulla M and Hospers, Geke A.P and Schröder, Carolina P and Fehrmann, Rudolf S.N and de Vries, Elisabeth G.E
Pharmacology and Therapeutics, ISSN 0163-7258, 08/2019, Volume 200, pp. 135 - 147
The androgen receptor (AR) is a drug target in breast cancer, and AR-targeted therapies have induced tumor responses in breast cancer patients. In this review,... 
AR antagonist | Estrogen receptor | Breast cancer | Human epidermal growth factor receptor 2 | Androgen receptor | Triple-negative breast cancer | PHASE-II | RANDOMIZED-TRIAL | CELL-PROLIFERATION | ADRENAL ANDROGENS | ESTROGEN | ABIRATERONE ACETATE | PHARMACOLOGY & PHARMACY | RESISTANT PROSTATE-CANCER | POSTMENOPAUSAL WOMEN | EXPRESSION | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Medical colleges | Pituitary hormones | RNA | Estrogen | Antibodies | Glycoproteins | Viral antibodies | Androgens | Epidermal growth factor | Analysis | Luteinizing hormone | Progesterone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. sup 18^F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
by Hilde H Nienhuis and Michel van Kruchten and Sjoerd G Elias and Andor WJM Glaudemans and Erik FJ de Vries and Alfons HH Bongaerts and Carolien P Schröder and Elisabeth GE de Vries and Geke AP Hospers
The Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, p. 1212
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
Cluster analysis | Liver | Estrogens | Estrogen | Estrogen receptors | Metastasis | Estradiol | Subgroups | Lymph nodes | Metastases | Confidence intervals | Heterogeneity | Computed tomography | Bones | Lesions | Medical imaging | Fluorine isotopes | Breast cancer | Patients | Sex hormones | Lungs | Breast | Bone | Tumors | Cancer | Lymph
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.